Show
Sort by
-
Luspatercept in patients with lower-risk myelodysplastic syndromes
-
- Journal Article
- A1
- open access
Pan-cancer analysis of whole genomes
-
The Medalist trial : results of a phase 3, randomized, double-blind, placebo-controlled study of luspatercept to treat anemia in patients with very low-, low-, or intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions
-
Long-acting bronchodilators improve Health Related Quality of Life in patients with COPD